CID 154699743

Losartan metabolite p1

Structural Information

Molecular Formula
C22H21ClN6O2
SMILES
CCCC(C1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C=O)Cl)O
InChI
InChI=1S/C22H21ClN6O2/c1-2-5-19(31)22-24-20(23)18(13-30)29(22)12-14-8-10-15(11-9-14)16-6-3-4-7-17(16)21-25-27-28-26-21/h3-4,6-11,13,19,31H,2,5,12H2,1H3,(H,25,26,27,28)
InChIKey
KMCNHKMBFGXFMW-UHFFFAOYSA-N
Compound name
5-chloro-2-(1-hydroxybutyl)-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carbaldehyde
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

0
References

0
Patents

436.14145 Da
Monoisotopic Mass

3.6
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 437.148726 201.0
[M+Na]+ 459.130668 210.7
[M-H]- 435.134174 205.2
[M+NH4]+ 454.175273 205.1
[M+K]+ 475.104608 201.4
[M+H-H2O]+ 419.138710 188.3
[M+HCOO]- 481.139651 211.6
[M+CH3COO]- 495.155301 208.4
[M+Na-2H]- 457.116116 198.4
[M]+ 436.14090142 205.2
[M]- 436.14199858 205.2
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.